Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2001, p. 1796-1801, Vol. 39, No. 5
Hamilton Regional Laboratory Medicine
Programme1 and Departments of Pathology
and Molecular Medicine2 and Clinical
Epidemiology and Biostatistics,3 McMaster
University, Hamilton, Ontario, Canada
Received 28 July 2000/Returned for modification 27 November
2000/Accepted 5 March 2001
Nucleic acid amplification of clinical specimens with low target
concentration has variable sensitivity. We examined whether testing
multiple aliquots of extracted DNA increased the sensitivity and
reproducibility of Chlamydia pneumoniae detection by PCR. Nested and non-nested C. pneumoniae PCR assays were
compared using 10 replicates of 16 serial dilutions of C. pneumoniae ATCC VR-1310. The proportion positive versus the
C. pneumoniae concentration was modeled by probit
regression analysis. To validate the model, 10 replicates of 26 previously positive patient specimens of peripheral blood mononuclear
cells (PBMC), sputum, or nasopharyngeal swabs (NPS) were tested. The
proportion of replicates that were positive varied with the
concentration of C. pneumoniae in the sample. At
concentrations above 5 infection-forming units (IFU)/ml, both nested
and non-nested PCR assay sensitivities were 90% or greater. The nested
PCR was more sensitive (median detection, 0.35 versus 0.61 IFU/ml;
relative median detection, 0.58; 95% confidence interval, 0.31 to
0.99; P = 0.04). In clinical specimens, replicate PCR detected 15 of 26 (nested) versus 1 of 26 (non-nested,
P < 0.001). For PBMC specimens, testing 1, 3, or 5 replicates detected 3, 5, or 9 of 10 positive specimens, respectively.
Median C. pneumoniae concentrations were estimated at 0.07 IFU/ml for PBMC and at <0.03 IFU/ml for NPS specimens. We conclude
that performing 5 or 10 replicates considerably increased the
sensitivity and reproducibility of C. pneumoniae PCR and
enabled quantitation for clinical specimens. Due to sampling
variability, PCR tests done without replication may miss a large
proportion of positive specimens, particularly for specimens with small
amounts of target C. pneumoniae DNA present.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.5.1796-1801.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Replicate PCR Testing and Probit Analysis for Detection and
Quantitation of Chlamydia pneumoniae in Clinical
Specimens
*
Corresponding author. Mailing address: Laboratory
Medicine L424, St. Joseph's Hospital, 50 Charlton Ave. East, Hamilton
ON L8N 4A6, Canada. Phone: 905-522-1155 (5140). Fax: 905-521-6083. E-mail: smiejam{at}mcmaster.ca.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|